Research and predictive analysis of the disease burden of bloodstream infectious diseases in China | BMC Infectious Diseases
Puopolo KM. Hospital-Onset Bacteremia-Counting them all. JAMA Pediatr. 2024;178:750–2.
Google Scholar
Martin-Loeches I, Singer M, Leone M. Sepsis: key insights, future directions, and immediate goals. A review and expert opinion. Intensive Care Med. 2024. https://doi.org/10.1007/s00134-024-07694-z.
Google Scholar
Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014;27:647–64.
Google Scholar
Collaborators AR. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London England). 2022;399:629.
Google Scholar
Zhang C, Fu X, Liu Y, Zhao H, Wang G. Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019. Lancet Reg Health: Western Pac. 2023;43:100972.
Oldenkamp R, Schultsz C, Mancini E, Cappuccio A. Filling the gaps in the global prevalence map of clinical antimicrobial resistance. Proc Natl Acad Sci USA. 2021;118:e2013515118.
Google Scholar
Hassoun-Kheir N, Guedes M, Ngo Nsoga M-T, Argante L, Arieti F, Gladstone BP, et al. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe. Clin Microbiol Infect. 2024;30(Suppl 1):S14–25.
Google Scholar
Kingston R, Vella V, Pouwels KB, Schmidt JE, Abdelatif El-Abasiri RA, Reyna-Villasmil E, et al. Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and bayesian meta-analysis. Clin Microbiol Infect. 2024;30(Suppl 1):S26–36.
Google Scholar
Pezzani MD, Arieti F, Rajendran NB, Barana B, Cappelli E, De Rui ME, et al. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review. Clin Microbiol Infect. 2024;30(Suppl 1):S4–13.
Google Scholar
Ashley EA, Recht J, Chua A, Dance D, Dhorda M, Thomas NV, et al. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000. J Antimicrob Chemother. 2018;73:1737.
Google Scholar
Liu Q, Liu X, Jiang B, Yang W. Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model. BMC Infect Dis. 2011;11:218.
Google Scholar
Sharafi M, Ghaem H, Tabatabaee HR, Faramarzi H. Forecasting the number of zoonotic cutaneous leishmaniasis cases in South of Fars Province, Iran using seasonal ARIMA time series method. Asian Pac J Trop Med. 2017;10:79–86.
Google Scholar
Guo W, Geng J, Zhan Y, Tan Y, Hu Z, Pan P, et al. Forecasting and predicting intussusception in children younger than 48 months in Suzhou using a seasonal autoregressive integrated moving average model. BMJ Open. 2019;9:e024712.
Google Scholar
Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199–226.
Google Scholar
Laupland KB, Lyytikäinen O, Sgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19:465–71.
Google Scholar
Kern WV, Rieg S. Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect. 2020;26:151–7.
Google Scholar
Souli M, Ruffin F, Choi S-H, Park LP, Gao S, Lent NC, et al. Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-Year, prospective, longitudinal study. Clin Infect Dis. 2019;69:1868–77.
Google Scholar
David MZ. The importance of Staphylococcus aureus genotypes in outcomes and complications of bacteremia. Clin Infect Dis. 2019;69:1878–80.
Google Scholar
Tacconelli E, Cataldo MA. Antimicrobial therapy of Staphylococcus aureus bloodstream infection. Expert Opin Pharmacother. 2007;8:2505–18.
Google Scholar
Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S344–349.
Google Scholar
Wang J-L, Chen S-Y, Wang J-T, Wu GH-M, Chiang W-C, Hsueh P-R, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis. 2008;46:799–806.
Google Scholar
Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect. 2007;54:427–34.
Google Scholar
Yan Guo F, Zhu HD, Wang F, Jiang X, Xu Y, et al. CHINET tertiary hospital bacterial resistance monitoring in 2022. Chin J Infect Chemother. 2024;24:277–86.
Daga AP, Koga VL, Soncini JGM, de Matos CM, Perugini MRE, Pelisson M, et al. Escherichia coli bloodstream infections in patients at a university hospital: virulence factors and clinical characteristics. Front Cell Infect Microbiol. 2019;9:191.
Google Scholar
Berger J, Diab-Elschahawi M, Blacky A, Pernicka E, Spertini V, Assadian O, et al. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance. Am J Infect Control. 2010;38:839–45.
Google Scholar
Kim SB, Min YH, Cheong J-W, Kim JS, Kim SJ, Ku NS, et al. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients. Scand J Infect Dis. 2014;46:81–8.
Google Scholar
Chen J, Li J, Huang F, Fang J, Cao Y, Zhang K, et al. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection. BMC Pulm Med. 2023;23:102.
Google Scholar
Lu J, Zhang A, Han L, Guo Z, Cui W, Jiang Y, et al. Clinical outcomes and risk factors for death following Carbapenem-Resistant Klebsiella pneumoniae infection in solid organ transplant recipients. Microbiol Spectr. 2023;11:e0475522.
Google Scholar
Yuan F, Xiao W, Wang X, Fu Y, Wei X. Clinical characteristics and prognosis of bloodstream infection with Carbapenem-Resistant Pseudomonas aeruginosa in patients with hematologic malignancies. Infect Drug Resist. 2023;16:4943–52.
Google Scholar
Cao Z, Yue C, Kong Q, Liu Y, Li J. Risk factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae bloodstream infection: A Five-Year retrospective study. Infect Drug Resist. 2022;15:641–54.
Google Scholar
Vandijck DM, Decruyenaere JM, Blot SI. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. J Infect. 2006;53:289; author reply 289–290.
Wei C, Chen J, Anwar TM, Huang L, Yang W, Dong X, et al. Genomic determinants of pathogenicity and antimicrobial resistance of nosocomial Acinetobacter baumannii clinical isolates of hospitalized patients (2019–2021) from a Sentinel hospital in Hangzhou, China. Infect Drug Resist. 2023;16:2939.
Google Scholar
Diao H, Lu G, Zhang Y, Wang Z, Liu X, Ma Q, et al. Risk factors for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infection of patients admitted in intensive care unit: a systematic review and meta-analysis. J Hosp Infect. 2024;149:77–87.
Google Scholar
Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F, et al. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022;50:83–92.
Google Scholar
Shi J, Sun T, Cui Y, Wang C, Wang F, Zhou Y, et al. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infect Dis. 2020;20:597.
Google Scholar
Liu Q, Li W, Du X, Li W, Zhong T, Tang Y, et al. Risk and prognostic factors for Multidrug-Resistant Acinetobacter Baumannii complex bacteremia: A retrospective study in a tertiary hospital of West China. PLoS ONE. 2015;10:e0130701.
Google Scholar
Huang C, Gao Y, Lin H, Fan Q, Chen L, Feng Y. Prognostic factors that affect mortality patients with Acinetobacter baumannii bloodstream infection. Infect Drug Resist. 2024;17:3825–37.
Google Scholar
Chen J, Xu Y, Tong D, Yang Y, Zhu FHD et al. Antimicrobial resistance changes of Acinetobacter spp. Isolated from CHINET patients from 2015 to 2021. Chin J Infect Chemother. 2023; 06:734-742.
Zhuo C, Guo Y, Zhuo C, Yang Y, Zhu FHD, et al. Changes in antimicrobial resistance of clinical isolates of Klebsiella species in CHINET from 2015 to 2021. Chin J Infect Chemother. 2024;24:418–26.
McNamara JF, Righi E, Wright H, Hartel GF, Harris PNA, Paterson DL. Long-term morbidity and mortality following bloodstream infection: A systematic literature review. J Infect. 2018;77:1–8.
Google Scholar
Diekema DJ, Hsueh P-R, Mendes RE, Pfaller MA, Rolston KV, Sader HS, et al. The microbiology of bloodstream infection: 20-Year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63:e00355.
Google Scholar
Weis S, Kimmig A, Hagel S, Pletz MW. Antibiotic stewardship am beispiel der Staphylococcus aureus Bakteriämie. Med Klin Intensivmed Notfmed. 2017;112:192–8.
Google Scholar
Song J-H, Jung S-I, Ko KS, Kim NY, Son JS, Chang H-H, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother. 2004;48:2101.
Google Scholar
Kim SH, Song J-H, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian network for surveillance of resistant pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012;56:1418–26.
Google Scholar
Li J, Liu L, Zhang H, Guo J, Wei X, Xue M, et al. Severe problem of macrolides resistance to common pathogens in China. Front Cell Infect Microbiol. 2023;13:1181633.
Google Scholar
Gang Li W, Wang W, Jia Y, Yang F, Zhu HD, et al. Surveillance of antimicrobial resistance in Streptococcus species: CHINET study 2015–2021. Chin J Infect Chemother. 2023;23:615–23.
Du Q, Liu Z, Wang H, Wang Y, Liu L, Wen X, et al. Nasopharyngeal carriage of Streptococcus pneumoniae among children aged 30 days to < 60 months in Beijing and Shenzhen, China (2018–2021) during Pneumococcal conjugate vaccine introduction and the coronavirus disease (COVID-19) pandemic. Front Pead. 2024;12:1382165.
Google Scholar
Zhang Y, Chen Y, Wang Z, Li Y, Wang D, Shang Y, et al. Serological and molecular capsular typing, antibiotic susceptibility and multilocus sequence typing OfStreptococcus pneumoniaeisolates from invasive and non-invasive infections. Chin Med J. 2013;126:2296.
Google Scholar
Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, et al. Antibiotic exposure as a risk factor for Fluconazole-Resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012;56:2518.
Google Scholar
Wang H, Xu Y-C, Hsueh P-R. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiol. 2016;11:1461–77.
Google Scholar
Xiao M, Sun Z-Y, Kang M, Guo D-W, Liao K, Chen SC-A, et al. Five-Year National surveillance of invasive candidiasis: species distribution and Azole susceptibility from the China hospital invasive fungal surveillance net (CHIF-NET) study. J Clin Microbiol. 2018;56:e00577–18.
Google Scholar
Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, et al. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of Microbiological data. Scand J Infect Dis. 2008;40:414–9.
Google Scholar
Billington EO, Phang SH, Gregson DB, Pitout JDD, Ross T, Church DL, et al. Incidence, risk factors, and outcomes for Enterococcus spp. Blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76–82.
Google Scholar
Hornuss D, Göpel S, Walker SV, Tobys D, Häcker G, Seifert H, et al. Epidemiological trends and susceptibility patterns of bloodstream Infections caused by Enterococcus spp. In six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group. Infection. 2024;52:1995–2004.
Google Scholar
Laupland KB, Pasquill K, Steele L, Parfitt EC. Burden of bloodstream infection in older persons: a population-based study. BMC Geriatr. 2021;21:31.
Google Scholar
Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, St Sauver JL, Wilson WR, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in olmsted County, Minnesota. Arch Intern Med. 2007;167:834–9.
Google Scholar
Mehl A, Åsvold BO, Lydersen S, Paulsen J, Solligård E, Damås JK, et al. Burden of bloodstream infection in an area of Mid-Norway 2002–2013: a prospective population-based observational study. BMC Infect Dis. 2017;17:205.
Google Scholar
Søgaard M, Schønheyder HC, Riis A, Sørensen HT, Nørgaard M. Short-term mortality in relation to age and comorbidity in older adults with community-acquired bacteremia: a population-based cohort study. J Am Geriatr Soc. 2008;56:1593–600.
Google Scholar
Crnich CJ, Zimmerman DR. Bacteremic outcomes in older adults: what is age telling Us?? J Am Geriatr Soc. 2008;56:1750–2.
Google Scholar
Kaye KS, Marchaim D, Chen T-Y, Baures T, Anderson DJ, Choi Y, et al. Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc. 2014;62:306–11.
Google Scholar
Leibovici-Weissman Y, Tau N, Yahav D. Bloodstream infections in the elderly: what is the real goal? Aging Clin Exp Res. 2021;33:1101–12.
Google Scholar
Pawelec G. Age and immunity: what is Immunosenescence?? Exp Gerontol. 2018;105:4–9.
Google Scholar
Hyernard C, Breining A, Duc S, Kobeh D, Dubos M, Prevel R, et al. Atypical presentation of bacteremia in older patients is a risk factor for death. Am J Med. 2019;132:1344–e13521.
Google Scholar
Posfay-Barbe KM, Wald ER. Pneumococcal vaccines: do they prevent infection and how? Curr Opin Infect Dis. 2004;17:177–84.
Google Scholar
Rodgers GL, Klugman KP. The future of Pneumococcal disease prevention. Vaccine. 2011;29(Suppl 3):C43–48.
Google Scholar
Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001;33:1959–67.
Google Scholar
Lee W-J, Hsu J-F, Chen Y-N, Wang S-H, Chu S-M, Huang H-R, et al. Pediatric Candida bloodstream infections complicated with mixed and subsequent bacteremia: the clinical characteristics and impacts on outcomes. J Fungi. 2022;8:1155.
Google Scholar
Lai M-Y, Hsu J-F, Chu S-M, Wu I-H, Huang H-R, Chiang M-C, et al. Risk factors and outcomes of recurrent candidemia in children: relapse or Re-Infection? J Clin Med. 2019;8:99.
Google Scholar
GBD 2021 Diseases and Injuries Collaborators.Global incidence. prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet.2024;403(10440):2133-2161.
Cheng X, Yang Y, Schwebel DC, Liu Z, Li L, Cheng P, et al. Population ageing and mortality during 1990–2017: A global decomposition analysis. PLoS Med. 2020;17:e1003138.
Google Scholar
Das S, Basu D, Manigandan G. Necrotizing fasciitis– A rare fatal outcome of road traffic accidents. Egypt J Forensic Sci. 2013;3:92–5.
Google Scholar
Lustenberger T, Turina M, Seifert B, Mica L, Keel M. The severity of injury and the extent of hemorrhagic shock predict the incidence of infectious complications in trauma patients. Eur J Trauma Emerg Surg. 2009;35:538–46.
Google Scholar
Sharma SK, Hadda V, Mathur P, Gulati V, Sahney C. Profile of micro-organisms in intensive care unit of a level-1 trauma centre: A retrospective study. Indian J Crit Care Medicine: Peer-reviewed Official Publication Indian Soc Crit Care Med. 2013;17:87.
Google Scholar
link
![Average Cost of Medical School [2025]: Yearly + Total Costs](https://educationdata.org/wp-content/uploads/2025/09/page-1.png "Average Cost of Medical School [2025]: Yearly + Total Costs")